ClinVar Miner

Submissions for variant NM_001312909.2(FAM111A):c.1706G>A (p.Arg569His) (rs587777011)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000419087 SCV000516941 pathogenic not provided 2018-09-11 criteria provided, single submitter clinical testing The R569H variant in the FAM111A gene is a known recurrent variant that is associated with Kenny-Caffey syndrome type 2 (Unger et al., 2013; Nikkel et al., 2013; Guo et al., 2014). The R569H variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Although the R569H variant is a conservative amino acid substitution which occurs at a position that is not conserved, molecular modeling has suggested the R569H substitution may disrupt the binding of FAM111A to partner proteins in the activation of the PTH axis (Unger et al., 2013). We interpret R569H as a pathogenic variant.
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000419087 SCV000861682 pathogenic not provided 2018-06-04 criteria provided, single submitter clinical testing
Mendelics RCV000988563 SCV001138329 pathogenic Osteocraniostenosis 2019-05-28 criteria provided, single submitter clinical testing
Ambry Genetics RCV001267015 SCV001445196 likely pathogenic Inborn genetic diseases 2018-02-02 criteria provided, single submitter clinical testing
OMIM RCV000050209 SCV000082785 pathogenic Kenny-Caffey syndrome type 2 2014-04-01 no assertion criteria provided literature only
ClinVar Staff, National Center for Biotechnology Information (NCBI) RCV000050209 SCV000244019 uncertain significance Kenny-Caffey syndrome type 2 2013-06-27 no assertion criteria provided literature only
Clinical Genetics Laboratory,Federal University of Health Sciences of Porto Alegre RCV000050209 SCV000996315 pathogenic Kenny-Caffey syndrome type 2 2014-05-22 no assertion criteria provided research
Institute of Medical Molecular Genetics, University of Zurich RCV000050209 SCV001297980 uncertain significance Kenny-Caffey syndrome type 2 2019-08-01 no assertion criteria provided research
GenomeConnect, ClinGen RCV001249420 SCV001423422 not provided Osteocraniostenosis; Kenny-Caffey syndrome type 2 no assertion provided phenotyping only Variant interpretted as Pathogenic and reported on 03-20-2019 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.